Optimal Duration of Antibiotic Treatment for Group A Streptococcal Pharyngitis in Children: A Systematic Review and Dose-Response Meta-Analysis
This systematic review and meta-analysis of 45 trials involving over 22,000 children suggests that for those at low risk of acute rheumatic fever, a 5-day course of oral antibiotics provides clinical benefits and safety comparable to the standard 10-day regimen, whereas evidence regarding 3-day courses remains uncertain.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Every year, millions of children visit doctors for a sore throat. While most of these cases are caused by common viruses that simply need rest and fluids, a smaller portion stems from a specific bacterium known as Group A Streptococcus. When this bacterium is the culprit, it can lead to complications, including a rare but serious condition called acute rheumatic fever, which can damage the heart. To prevent these issues and ease symptoms, doctors have long prescribed antibiotics. For decades, the standard rule has been to take these medicines for ten days. This long course was established in the mid-twentieth century based on the idea that a shorter treatment might leave some bacteria alive, potentially allowing the infection to return or trigger the dangerous heart condition. However, taking antibiotics for a long time can disrupt the body's natural balance, cause side effects, and contribute to the growing problem of drug-resistant bacteria. This has led many to wonder if a shorter course could work just as well without the downsides.
A team of researchers set out to answer this question by gathering and analyzing data from dozens of studies involving thousands of children. They looked at randomized trials where children with confirmed strep throat were given antibiotics for different lengths of time, ranging from just a few days up to the standard ten days. The researchers focused on outcomes that matter most to patients and families: whether the child was cured, if the infection came back, and if any harmful side effects occurred. They also paid close attention to rare but serious complications like rheumatic fever. By combining the results of forty-five separate trials that included more than twenty-two thousand participants, the team was able to see the full picture of how treatment duration affects health.
The analysis suggests that for children who are at low risk of developing rheumatic fever, taking antibiotics for five days is likely just as effective as taking them for ten days. The researchers found no meaningful difference in the rate of clinical cure between the two groups. In practical terms, this means that if a child takes medicine for five days instead of ten, they are just as likely to recover fully. Similarly, the chance of the infection returning after treatment ended was nearly identical for both groups. The study also looked at adverse events, such as stomach upset or rashes, and found that the number of these problems was similar whether the child took the medicine for five days or ten. This indicates that shortening the course does not increase the risk of side effects, nor does it seem to offer a significant reduction in them, but it does reduce the total amount of medication the child consumes.
The evidence supporting a five-day course is considered moderate in strength, meaning the researchers are confident in the finding but acknowledge some limitations in the original studies, such as a lack of blinding where participants knew which treatment they received. However, the consistency of the results across many different trials and antibiotic types strengthens the conclusion. The researchers also tested whether the type of antibiotic mattered, specifically looking at penicillins, which are the most common choice. Even when they focused only on these specific drugs, the results held true: five days appeared to work as well as ten.
The picture is less clear for treatments lasting only three days. While the data showed no major difference in outcomes for this very short duration, almost all the studies on three-day regimens used a specific type of antibiotic called azithromycin. This drug stays active in the body for a long time after the last dose is taken, which makes it difficult to know if the results would apply to other common antibiotics like penicillin. Because of this, the researchers cannot yet say with confidence that a three-day course of penicillin or similar drugs is safe or effective. They also noted that serious complications like acute rheumatic fever were extremely rare in the studies, occurring in only a handful of children across the entire group. This rarity makes it unlikely that a shorter course would lead to a noticeable increase in these severe outcomes for children in low-risk populations, though the data is not large enough to rule out small differences entirely.
Ultimately, the findings suggest that the long-standing ten-day rule may be more than what is necessary for many children. For those in low-risk settings, a five-day course of oral antibiotics likely provides the same protection against the infection and its return while reducing the burden of daily medication and limiting exposure to drugs. This could help lower the overall use of antibiotics, which is a key step in slowing the development of drug-resistant bacteria. While the standard of care in many places remains ten days, this research offers a strong basis for doctors and families to consider shorter treatments. The study does not recommend three-day courses for common antibiotics yet, as more research is needed to confirm their safety and effectiveness. For now, the evidence points to a middle ground: five days appears to be a safe and effective alternative to the traditional ten-day regimen for most children with strep throat.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.